Pharma Journalist - Page 55 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

China Approves LEQEMBI IV Maintenance Dosing for Early Alzheimer’s

FDA Approves TREMFYA for Pediatric Psoriasis and Psoriatic Arthritis

Dyne Therapeutics’ DYNE-251 Gains Orphan Drug Status in Japan for Duchenne Muscular Dystrophy

Amgen to Invest $650 Million in U.S. Manufacturing Expansion, Creating Nearly 750 Jobs

FDA Approves Evkeeza for Youngest Children with Rare Genetic Cholesterol Disorder

Er-Kim and Sentynl Therapeutics Partner to Expand Access to Rare Disease Treatments in EMEA and Eurasian Markets

Biostar Pharma’s Utidelone Receives Third Orphan Drug Designation from FDA for Pancreatic Cancer

Eli Lilly Expands Innovation Network with New Gateway Labs Site in San Diego

Lonza’s Synaffix Partners with Qurient to Develop Dual-Payload ADC

Basilea Secures BARDA Contract for Phase 3 Oral Antibiotic Development